Literature DB >> 12967706

Fatal outcome of SARS in a patient with reactivation of chronic hepatitis B.

Alex Y Hui, Henry L Y Chan, Choong-Tsek Liew, Paul K S Chan, Ka-Fai To, Chin-Pang Chan, Joseph J Y Sung.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12967706      PMCID： PMC7124200          DOI： 10.1016/s0002-9343(03)00363-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  9 in total

1.  Fatal submassive hepatic necrosis associated with tyrosine-methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy.

Authors:  J W Kim; H S Lee; G H Woo; J H Yoon; J J Jang; J G Chi; C Y Kim
Journal:  Clin Infect Dis       Date:  2001-07-07       Impact factor: 9.079

2.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

3.  Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.

Authors:  W Yeo; J L Steinberg; J S Tam; P K Chan; N W Leung; K C Lam; T S Mok; P J Johnson
Journal:  J Med Virol       Date:  1999-11       Impact factor: 2.327

4.  The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice.

Authors:  H L-Y Chan; S W-C Tsang; Y Hui; N W-Y Leung; F K-L Chan; J J-Y Sung
Journal:  J Viral Hepat       Date:  2002-11       Impact factor: 3.728

5.  Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy.

Authors:  C M Maguire; D H Crawford; L F Hourigan; A D Clouston; E T Walpole; E E Powell
Journal:  J Gastroenterol Hepatol       Date:  1999-08       Impact factor: 4.029

6.  Pathologic features of the liver in acquired immune deficiency syndrome (AIDS).

Authors:  Y Nakanuma; C T Liew; R L Peters; S Govindarajan
Journal:  Liver       Date:  1986-06

7.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.

Authors:  J S M Peiris; C M Chu; V C C Cheng; K S Chan; I F N Hung; L L M Poon; K I Law; B S F Tang; T Y W Hon; C S Chan; K H Chan; J S C Ng; B J Zheng; W L Ng; R W M Lai; Y Guan; K Y Yuen
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

8.  Lung pathology of fatal severe acute respiratory syndrome.

Authors:  John M Nicholls; Leo L M Poon; Kam C Lee; Wai F Ng; Sik T Lai; Chung Y Leung; Chung M Chu; Pak K Hui; Kong L Mak; Wilina Lim; Kin W Yan; Kwok H Chan; Ngai C Tsang; Yi Guan; Kwok Y Yuen; J S Malik Peiris
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

9.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.

Authors:  Christl A Donnelly; Azra C Ghani; Gabriel M Leung; Anthony J Hedley; Christophe Fraser; Steven Riley; Laith J Abu-Raddad; Lai-Ming Ho; Thuan-Quoc Thach; Patsy Chau; King-Pan Chan; Tai-Hing Lam; Lai-Yin Tse; Thomas Tsang; Shao-Haei Liu; James H B Kong; Edith M C Lau; Neil M Ferguson; Roy M Anderson
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321
  9 in total
  1 in total

1.  Clinical significance of hepatic derangement in severe acute respiratory syndrome.

Authors:  Henry-Lik-Yuen Chan; Ambrose-Chi-Pong Kwan; Ka-Fai To; Sik-To Lai; Paul Kay-Sheung Chan; Wai-Keung Leung; Nelson Lee; Alan Wu; Joseph Jao-Yiu Sung
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.